Today: 7 February 2026
Subscribe

Perpetua Resources (PPTA) Stock News Today: Hatch Named EPCM for Stibnite Gold Project, New Private Placement Details, and Updated Analyst Targets (Dec. 16, 2025)

Perpetua Resources (PPTA) Stock News Today: Hatch Named EPCM for Stibnite Gold Project, New Private Placement Details, and Updated Analyst Targets (Dec. 16, 2025)

BOISE, Idaho — December 16, 2025 — Perpetua Resources Corp. (Nasdaq: PPTA / TSX: PPTA) is back in the spotlight today after announcing a major project execution milestone for its flagship Stibnite Gold Project in Idaho: the company has selected Hatch Ltd. as Engineering, Procurement, and Construction Management (EPCM) contractor. Alongside that headline, a new regulatory filing adds fresh color on the financing picture—including a separate private placement with warrants and a community-related share issuance—giving investors more to chew on than a single press-release headline. As of 16:32 UTC (11:32 a.m. ET) on December 16, PPTA traded at $26.82, essentially
16 December 2025
·····
Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs Inc. (NYSE: CLF) is back in the spotlight on Tuesday, December 16, 2025, as investors weigh a classic “steel-cycle” tug-of-war: improving operating tailwinds versus balance-sheet pressure. In Tuesday’s trading, CLF stock hovered around $12.85, modestly higher on the day, after opening near $12.76 and trading roughly between $12.69 and $12.94. The near-term narrative for Cleveland-Cliffs stock is being shaped by three overlapping themes: Below is a detailed look at the latest Cleveland-Cliffs news, forecasts, and analyst views as of 12/16/2025—and what market participants are watching next. Why Cleveland-Cliffs stock is “eventful” right now Cleveland-Cliffs is not just another steel
16 December 2025
··
Sarepta Therapeutics (SRPT) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Sarepta Therapeutics (SRPT) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is back in the spotlight on Tuesday, December 16, 2025—not because the story suddenly got simpler, but because it’s at the intersection of three things the market obsessively prices every day: regulatory risk, clinical evidence, and cash runway. SRPT shares traded around $22 in the U.S. session on Dec. 16, up roughly a couple percent in morning trading. StockAnalysis That price level is a reminder of how dramatically sentiment has reset in 2025: Sarepta’s market capitalization now sits in the low single-digit billions (roughly $2–$3B, depending on intraday moves). StockAnalysis+2Yahoo Finance+2 So what’s “current” as
16 December 2025
·····
ATS Corporation Stock Surges After CEO Appointment: Latest News, Stock Price, Analyst Targets and Outlook (Dec. 16, 2025)

ATS Corporation Stock Surges After CEO Appointment: Latest News, Stock Price, Analyst Targets and Outlook (Dec. 16, 2025)

ATS Corporation (TSX: ATS; NYSE: ATS) is in the spotlight on Tuesday, December 16, 2025, after the Canadian automation specialist announced a key leadership decision: Doug Wright has been appointed Chief Executive Officer and will also join the company’s Board of Directors, with the transition expected to take place on or before January 14, 2026. ATS Automation The market’s initial reaction was upbeat. ATS shares traded higher on both listings, reflecting investor relief that a months-long CEO search is now resolved—often a “de-risking” moment for a stock that’s trying to refocus attention on operations, margins, and backlog conversion. ATS stock
16 December 2025
······
Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) is back in focus on Tuesday, December 16, 2025, after a strong rebound in the prior session and a fresh wave of market commentary ranging from technical-analysis signals to institutional-filings headlines and updated Wall Street expectations. As of late morning U.S. trading, ISRG traded around $548–$549, down roughly 2% on the day, valuing the surgical-robotics leader at about $194 billion in market capitalization. StockAnalysis+1 Below is a comprehensive, publication-ready roundup of the news, forecasts, and analyses circulating on 16.12.2025, plus the key catalysts investors are watching into early 2026. ISRG stock price today: a pullback
16 December 2025
·····
Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials, Inc. (NASDAQ: AMAT) is back in the spotlight on December 16, 2025, as fresh industry forecasts and a wave of Wall Street price-target increases reinforce a central narrative for semiconductor equipment investors: the AI buildout is pulling forward demand for leading-edge logic, memory (especially HBM-related DRAM), and advanced packaging—exactly the mix where Applied Materials has been positioning its portfolio. As of the latest available quote on December 16, AMAT shares traded around $257, down roughly 1.6% on the day, after moving between roughly $256 and $262. AMAT stock price action: what the market is signaling on Dec. 16
16 December 2025
·····
Southwest Airlines Stock (NYSE: LUV) Surges on Barclays Upgrade: Today’s News, Analyst Forecasts, and Key Risks (Dec. 16, 2025)

Southwest Airlines Stock (NYSE: LUV) Surges on Barclays Upgrade: Today’s News, Analyst Forecasts, and Key Risks (Dec. 16, 2025)

Southwest Airlines Co. stock is in the spotlight on Tuesday, Dec. 16, 2025, as shares push higher again—extending a sharp early-December rally that has re-rated the airline in the eyes of momentum traders and (increasingly) Wall Street analysts. In late morning trading, LUV was up roughly 2%–3% and hovering around the low-$40s. StockAnalysis+1 The immediate catalyst: Barclays upgraded Southwest to Overweight from Equalweight and lifted its price target to $56 from $34, a dramatic move that helped keep the stock bid even as broader markets softened. Investing.com+2Barchart.com+2 But the bigger story for investors isn’t just a one-day analyst call. It’s
16 December 2025
····
Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck & Co., Inc. (NYSE: MRK) stock was among the biggest drags on the Dow Jones Industrial Average in Tuesday’s session (December 16, 2025), with shares trading lower as investors weighed broad market pressure alongside a fast-moving set of company-specific catalysts—ranging from regulatory momentum for Winrevair to ongoing efforts to protect Keytruda ahead of looming patent headwinds. MarketWatch+1 As of the latest trade at 16:41 UTC, Merck shares were $98.05, down 2.21% on the day, after trading between $96.85 and $100.49. Merck stock price action on Dec. 16: a Dow-weighted drop with no single headline Merck’s decline mattered more than
16 December 2025
···
IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Falling, What Analysts Forecast, and How the Microsoft AI Deal Shapes 2026 (Dec. 16, 2025)

IREN Limited stock is back in the spotlight on December 16, 2025, as the high-flying “AI infrastructure” trade collides with a sharp momentum pullback — even while the company continues to point to a massive long-term runway from its GPU cloud pivot and headline-grabbing Microsoft agreement. As of 16:39 UTC on Dec. 16, IREN was trading around $34.19, down about 3.6% on the session after opening near $34.83, with an intraday range of roughly $33.38 to $35.84 and volume above 22 million shares. This comes a day after a steep selloff: IREN shares fell 11.59% on Monday (Dec. 15), extending
16 December 2025
·····
Carvana Stock (CVNA) News Today, Dec. 16, 2025: Argus Starts Coverage With a $500 Target as S&P 500 Entry Nears

Carvana Stock (CVNA) News Today, Dec. 16, 2025: Argus Starts Coverage With a $500 Target as S&P 500 Entry Nears

Carvana Co. (NYSE: CVNA) is back at the center of Wall Street’s attention on December 16, 2025, as the online used‑car retailer heads toward a major index milestone and picks up fresh analyst support. Shares were trading at $457.76, up about 2.2% on the session, after moving between $445.00 and $464.29 intraday (about 1.39 million shares traded as of 16:31 UTC). The headline catalyst driving today’s chatter: Argus Research initiated coverage with a “Buy” rating and a $500 price target, a call that keeps the spotlight on a stock that has already delivered a dramatic multi‑year rebound—and is now days
16 December 2025
·····
Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs Group, Inc. (The) stock (NYSE: GS) is back in the spotlight on December 16, 2025, with a mix of regulatory, strategic, and market-structure headlines landing as the shares hover near recent highs. As of the latest available market data on Dec. 16, GS traded around $881.68, down about 0.9% versus the prior close. That price action comes as investors digest three storylines that matter for the next leg of Goldman’s valuation: (1) a key Federal Reserve enforcement action termination, (2) the firm’s repositioning for AI- and infrastructure-driven dealmaking, and (3) the industry’s slow march toward nearly round-the-clock U.S.
16 December 2025
·····
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could clarify the company’s 2026 trajectory. StockAnalysis+1 Below is what’s moving Johnson & Johnson shares right now, what Wall Street is forecasting, and the key dates JNJ stock watchers have on the calendar. JNJ stock price check: what’s happening on Dec. 16, 2025 As of late morning U.S. time on December 16, JNJ stock was trading around the $211–$212 area, down
16 December 2025
·····
1 … 1,488 1,489 1,490 1,491 1,492 … 2,709

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop